107 completed, 18 unknown, 14 recruiting, 10 active not recruiting. 64 Phase 3, 34 Phase 2, 27 Phase 4, 18 Phase 1, 6 Not applicable.
Follow Chickenpox: new trials by email Literature Review of Chickenpox trials Research Report on Chickenpox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial Two-dose M0-M2 vaccination schedule, Two-dose M0-M6 vaccination schedule - Vaccine, Varicella-zoster Virus | Phase 4 | Not yet recruiting | University Hospital, Toulouse | 160 | 2026-10-20 | 2026-09-14 |
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age MMRVNS vaccine, MMRV vaccine, DTaP-IPV vaccine - Measles, Mumps | Phase 3 | Not yet recruiting | GlaxoSmithKline | 1860 | 2026-08-11 | 2026-08-03 |
| SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years NBP608 (Mid Potency), NBP608 (Low Potency), Varivax® - Varicella (Chickenpox) | Phase 3 | Recruiting | SK Bioscience Co., Ltd. | 780 | 2026-07-04 | 2026-09-15 |
| Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above ABO1108, Placebo - Varicella-zoster Virus | Phase 3 | Recruiting | Suzhou Abogen Biosciences Co., Ltd. | 18000 | 2026-06-27 | 2026-09-14 |
| Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Varicella Vaccine - Varicella (Chickenpox), Varicella Immunisation | Phase 3 | Not yet recruiting | Sinovac (Dalian) Vaccine Technology Co., Ltd. | 300 | 2026-06-15 | 2026-06-12 |
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age MMRVNS, MMRV - Measles, Measles-Mumps-Rubella+Chickenpox Vaccine | Phase 3 | Recruiting | GlaxoSmithKline | 1209 | 2026-05-11 | 2026-07-08 |
| A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants HZ Vaccine (IN001), Shingrix - Herpes Zoster | Phase 2 | Not yet recruiting | Shenzhen Shenxin Biotechnology Co., Ltd | 480 | 2026-05-01 | 2025-10-07 |
| Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above Shingrix, CVI-VZV-001 - Herpes Zoster | Phase 2 | Active not recruiting | Aribio Lab Co., Ltd. | 135 | 2026-04-17 | 2026-10-28 |
| Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation Booster dose of the recombinant zoster vaccine (RZV, Shingrix®) - Zoster; Herpes | Phase 2 | Not yet recruiting | Oriol Manuel | 75 | 2026-04-01 | 2026-03-02 |
| A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years MG1111 (Barycela inj.), VARIVAX™ - Varicella (Chickenpox), Chickenpox Vaccine | Phase 3 | Recruiting | GC Biopharma Corp | 474 | 2026-03-17 | 2026-04-17 |
| Second Dose of Varicella Vaccine in Healthy Children PROVARIX - Varicella (Chickenpox), Varicella Immunisation | Phase 3 | Recruiting | Sinovac (Dalian) Vaccine Technology Co., Ltd. | 300 | 2026-01-28 | 2026-03-16 |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above ABO1108, Placebo - Varicella-zoster Virus | Phase 2 | Active not recruiting | Suzhou Abogen Biosciences Co., Ltd. | 300 | 2025-11-15 | 2026-05-11 |
| A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older Low dose antigen and low dose adjuvant of LYB004, Low dose antigen and high dose adjuvant of LYB004, High dose antigen and low dose adjuvant of LYB004 - Herpes Zoster (HZ), Shingles | Phase 2 | Active not recruiting | Guangzhou Patronus Biotech Co., Ltd. | 840 | 2025-10-23 | 2025-12-30 |
| Correlation of Protection Against Varicella in an Exploratory Study Varicella vaccine - Varicella | Not yet recruiting | Sinovac (Dalian) Vaccine Technology Co., Ltd. | 400 | 2025-10-10 | 2025-01-27 | |
| Evaluation of the Anti-VZV Vaccine Response of Patients With Immune-mediated Systemic Inflammatory Diseases Vaccinated in the Care Setting Vaccination Varicella-zoster Virus, Immune-mediated Systemic Inflammatory Diseases | Recruiting | Assistance Publique - Hôpitaux de Paris | 50 | 2025-06-10 | 2025-07-02 | |
| Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above ABO1108, Placebo, SHINGRIX - Varicella-zoster Virus | Phase 1 | Active not recruiting | Suzhou Abogen Biosciences Co., Ltd. | 180 | 2025-05-27 | 2026-05-11 |
| A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age Investigational varicella vaccine, Marketed varicella vaccine, MMR vaccine - Chickenpox | Phase 3 | Recruiting | GlaxoSmithKline | 600 | 2025-05-15 | 2026-05-29 |
| Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine Vaicella Vaccine+DTaP on Day 0, MMR on Day 30, Varicella vaccine+MMR on Day 0，DTaP on Day 30, Varicella Vaccine - Varicella (chickenpox), MMR Vaccine | Phase 4 | Not yet recruiting | Sinovac (Dalian) Vaccine Technology Co., Ltd. | 720 | 2025-05-01 | 2025-03-24 |
| A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age Candidate varicella vaccine, Marketed varicella vaccine, MMR vaccine - Chickenpox | Phase 3 | Recruiting | GlaxoSmithKline | 911 | 2025-04-17 | 2026-05-29 |
Showing 20 of 169. Sign in to see all of them.
Measles (45) · Mumps (44) · Rubella (44) · Herpes Zoster (35) · HIV Infections (8) · Varicella Zoster Virus Infection (6) · AIDS-Related Complex (5) · Hepatitis A (5) · Acquired Immunodeficiency Syndrome (4) · Haemophilus Infections (4) · Herpesviridae Infections (4) · Neuralgia, Postherpetic (4) · Virus Diseases (4) · Communicable Diseases (3)
DNA Virus Infections (166) · Infections (166) · Herpesviridae Infections (165) · Virus Diseases (165) · Varicella Zoster Virus Infection (163) · RNA Virus Infections (60) · Mononegavirales Infections (45) · Morbillivirus Infections (45) · Paramyxoviridae Infections (45) · Stomatognathic Diseases (45) · Mouth Diseases (44) · Parotid Diseases (44) · Parotitis (44) · Rubivirus Infections (44) · Rubulavirus Infections (44)
Chickenpox Vaccine (28) · measles, mumps, rubella, varicella vaccine (21) · Herpes Zoster Vaccine (12) · Measles-Mumps-Rubella Vaccine (12) · Hepatitis A Vaccines (10) · Pneumococcal Vaccines (5) · Valacyclovir (4) · Blood Specimen Collection (3) · Heptavalent Pneumococcal Conjugate Vaccine (3) · Meningococcal Vaccines (3) · Priorix-Tetra vaccine (3) · Vaccines (3) · Vaccines, Attenuated (3) · sorivudine (3) · Acyclovir (2)
GlaxoSmithKline (34) · Merck Sharp & Dohme LLC (27) · Sinovac (Dalian) Vaccine Technology Co., Ltd. (16) · National Institute of Allergy and Infectious Diseases (NIAID) (9) · Sanofi Pasteur, a Sanofi Company (5) · Beijing Center for Disease Control and Prevention (3) · Changchun Keygen Biological Products Co., Ltd. (3) · Guangzhou Patronus Biotech Co., Ltd. (3) · Suzhou Abogen Biosciences Co., Ltd. (3) · University of Colorado, Denver (3) · China National Biotec Group Company Limited (2) · GC Biopharma Corp (2) · Green Cross Corporation (2) · SK Bioscience Co., Ltd. (2) · Shanghai Municipal Center for Disease Control and Prevention (2)
United States (41) · China (28) · Germany (13) · Italy (7) · Poland (7) · Thailand (7) · Czechia (6) · France (6) · South Korea (6) · Canada (5) · Estonia (5) · Philippines (5) · Puerto Rico (5) · Belgium (4) · Mexico (4)
Nianmin Shi (3) · Shengli Xia (3) · Annemette Hald, RN (2) · Hongxing Pan (2) · Huizhen Zheng, Master (2) · Lili Huang, Bachelor (2) · Sunil K Saini, MSc, PhD (2) · Adit A Ginde, MD, MPH (1) · Ahad Sabet, MD (1) · Allan Rasmussen, MD (1) · Allison Kempe, MD, MPH (1)
PMID 10891827, PMID 12683413, PMID 12850341, PMID 15734076, PMID 15962639, PMID 16094218, PMID 16452343, PMID 16567978, PMID 16804432, PMID 17332177, PMID 17502347, PMID 18652095, PMID 19273678, PMID 19305145, PMID 19366435, PMID 19469706, PMID 21934474, PMID 22123890, PMID 22406278, PMID 22566415, PMID 22772170, PMID 22872734, PMID 23066488, PMID 23217121, PMID 23545380, PMID 23694831, PMID 24990909, PMID 25272081, PMID 25765966, PMID 26362659, PMID 26762528, PMID 27149048, PMID 27171749, PMID 27423382, PMID 27707807, PMID 28183713, PMID 28939581, PMID 29087781, PMID 29309521, PMID 29325161, PMID 29461919, PMID 29590326, PMID 29800309, PMID 30481110, PMID 30498306, PMID 30511963, PMID 30616012, PMID 30765242, PMID 30975567, PMID 31282539
2025 (3), 2004 (1), 2008 (1), 2017 (1), 2019 (1), K23AG040708 (1), P01CA094237 (1), R01AG018367 (1), U01IP000129 (1), U10EY026869 (1), U19AI090023 (1)